Molineaux L
Kenya Medical Research Institute, CRC, Kilifi Unit, Kenya.
Ann Trop Med Parasitol. 1996 Aug;90(4):379-93. doi: 10.1080/00034983.1996.11813067.
Observations are accumulating concerning: (1) the antigenic diversity of Plasmodium falciparum; (2) the diversity of the genetic immuno-competence of human hosts; (3) the associations between these diversities and disease, protection and defined immune responses; and (4) the possible mechanisms of acquired protection at different steps of the host-parasite interaction. These observations have led to speculations concerning the distribution of disease, the acquisition of protection, and vaccination prospects. Speculations on the latter have varied from pessimism about the possibility of developing a vaccine that would protect most people against most parasites, to optimism based on the hypothesis that a local P. falciparum population is composed of a few discrete subpopulations. If this hypothesis is correct, it may be possible to prevent most severe disease with a narrow-spectrum vaccination against a virulent minority of the subpopulations, or transmission could be interrupted by a relatively low coverage of a broad-spectrum vaccination. A conceptual model that might accommodate the observations is outlined. Its plausibility and testability are considered, as well as some of its implications for the planning and interpretation of epidemiological surveys and intervention trials, and perhaps for selection of antigens for inclusion in vaccines.
(1)恶性疟原虫的抗原多样性;(2)人类宿主的遗传免疫能力多样性;(3)这些多样性与疾病、保护作用及明确的免疫反应之间的关联;以及(4)在宿主 - 寄生虫相互作用的不同阶段获得保护的可能机制。这些观察结果引发了关于疾病分布、获得保护以及疫苗接种前景的种种推测。关于后者的推测各不相同,从对研发一种能保护大多数人抵御大多数寄生虫的疫苗可能性的悲观态度,到基于当地恶性疟原虫群体由少数离散亚群组成这一假设的乐观态度。如果这一假设正确,那么有可能通过针对少数毒性亚群的窄谱疫苗接种来预防大多数严重疾病,或者通过相对较低覆盖率的广谱疫苗接种来阻断传播。本文概述了一个可能符合这些观察结果的概念模型。探讨了其合理性和可测试性,以及它对流行病学调查和干预试验的规划与解读,或许还有对疫苗中所含抗原选择的一些影响。